The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Personalized frailty risk assessment in long-term survivors of colorectal cancer.
 
Rebecca Forman
No Relationships to Disclose
 
Sarah Westvold
No Relationships to Disclose
 
Jessica Long
No Relationships to Disclose
 
Jane Fan
No Relationships to Disclose
 
Terry Hyslop
Research Funding - Pfizer
 
Faiza Yasin
No Relationships to Disclose
 
Kerry Conlin
No Relationships to Disclose
 
Sofia Jacobson
No Relationships to Disclose
 
Andrea Silber
Honoraria - AstraZeneca/Daiichi Sankyo
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo
 
Shi-Yi Wang
No Relationships to Disclose
 
Michael Leapman
(OPTIONAL) Uncompensated Relationships - Veracyte
 
Ira Leeds
Consulting or Advisory Role - Intuitive Surgical
 
Michael Cecchini
Stock and Other Ownership Interests - Parthenon Therapeutics
Honoraria - Agenus; Arcus Biosciences; AstraZeneca; Bayer; BeiGene; Daiichi Sankyo/Astra Zeneca; DAVA Pharmaceuticals; Elevation Oncology; Incendia Therapeutics; Loxo/Lilly; Macrogenics; Modifi Bio; Regeneron; Seagen; Taiho Oncology
 
Lisa Spees
Research Funding - AstraZeneca/Merck
 
Stephanie Wheeler
Research Funding - AstraZeneca (Inst); Pfizer (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Cary Gross
Research Funding - AstraZeneca (Inst); Johnson & Johnson (Inst)
 
Kevin Oeffinger
Leadership - Maia Oncology, Inc
Stock and Other Ownership Interests - Maia Oncology, Inc
Consulting or Advisory Role - Maia Oncology, Inc
Research Funding - GRAIL (Inst)
 
Michaela Dinan
Research Funding - AstraZeneca (Inst); Janssen (I)